Intas Pharmaceuticals Ltd.

Intas Pharmaceuticals, Ltd., is a global company leading in the development, manufacturing and marketing of pharmaceutical formulations, including Generics, Biosimilars and Added Value Medicines.

Intas delivered sales of USD 2.5 billion in 2022-23, it is present in more than 85 countries worldwide and is growing at ~20% CAGR. Around 70% of its revenues come from the international markets, particularly the highly regulated markets of EU and US.

Intas currently operates 5 GMP sites in India, 2 in UK and 1 in Mexico, capable of doing tabs, caps, effervescent tabs, oi...